MN Healthcare

A triple-therapy inhalation powder containing:

• Fluticasone furoate 100 mcg – corticosteroid (reduces airway inflammation)

• Umeclidinium 62.5 mcg – LAMA bronchodilator (relaxes airway muscles)

• Vilanterol 25 mcg – LABA bronchodilator (keeps airways open)

Form: Dry powder for inhalation
Type: Allopathic respiratory medicine

• Chronic Obstructive Pulmonary Disease (COPD)

• Maintenance treatment of airflow obstruction

• Helps reduce symptoms like wheezing, breathlessness, chronic cough

(Not for sudden asthma/COPD attacks.)

• Shelf life: 24 months (2 years) from date of manufacture
  (Most DPI triple-therapy inhalers carry 24 months unless otherwise labeled.)

• Store below 30°C

• Keep in a dry place

• Do not puncture or expose to moisture

• Keep inside the original sealed tray until use

• After opening tray: use within the timeframe specified on pack (usually 6 weeks)

Generic name: Budesonide
Strength: 0.5 mg per respule (nebule / vial)
Dosage form: Nebuliser suspension
Product type: Prescription respiratory anti-inflammatory medicine

Used for long-term control and prevention of:

• Bronchial asthma

• Chronic obstructive pulmonary disease (COPD)

• Wheezing in children

• Allergic airway inflammation

• Post-infectious or inflammatory airway disease (doctor prescribed)

Reduces swelling and irritation in the airways, making breathing easier and preventing asthma attacks.

• Adults and children (dose depends on age and severity)

• Commonly prescribed in pediatrics under supervision

Used via nebulizer machine by inhalation.
Do not swallow or inject.

Hoarseness, cough, throat irritation, oral thrush.

Store below 25°C, protect from light.
Do not freeze.

Usually 24–36 months (check printed pack).